[Clinical evaluation of serum CEA levels in uterine cervix cancer]. 1983

Y Kikuchi, and J Hirose, and Y Uekita, and K Hayasaka, and A Asano, and S Nishino, and H Mitsuhashi, and K Amo, and N Washizuka, and I Mure, and Y Yamashita

Serum CEA levels were measured in the blood of 98 patients with uterine cervix cancer before, during, and after treatment to investigate the relationship among the CEA level, the extent of the disease, and recovery. The CEA level rose as the disease progressed. Although there was no significant difference in the survival rates of patients with various CEA levels, those who returned to normal levels after treatment recuperated better. There was not clear evidence that CEA levels are clinically significant. However, it can be concluded that CEA levels at pre- and post-treatment times are helpful in the early detection of disease, prognosis, and in predicting recurrence or metastasis.

UI MeSH Term Description Entries
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D002272 Carcinoembryonic Antigen A glycoprotein that is secreted into the luminal surface of the epithelia in the gastrointestinal tract. It is found in the feces and pancreaticobiliary secretions and is used to monitor the response to colon cancer treatment. Antigens, CD66e,CD66e Antigen,Antigen, CD66e,Antigen, Carcinoembryonic,CD66e Antigens
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Y Kikuchi, and J Hirose, and Y Uekita, and K Hayasaka, and A Asano, and S Nishino, and H Mitsuhashi, and K Amo, and N Washizuka, and I Mure, and Y Yamashita
September 1984, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica,
Y Kikuchi, and J Hirose, and Y Uekita, and K Hayasaka, and A Asano, and S Nishino, and H Mitsuhashi, and K Amo, and N Washizuka, and I Mure, and Y Yamashita
November 1986, Rinsho hoshasen. Clinical radiography,
Y Kikuchi, and J Hirose, and Y Uekita, and K Hayasaka, and A Asano, and S Nishino, and H Mitsuhashi, and K Amo, and N Washizuka, and I Mure, and Y Yamashita
December 1986, Nihon Gan Chiryo Gakkai shi,
Y Kikuchi, and J Hirose, and Y Uekita, and K Hayasaka, and A Asano, and S Nishino, and H Mitsuhashi, and K Amo, and N Washizuka, and I Mure, and Y Yamashita
October 2009, Croatian medical journal,
Y Kikuchi, and J Hirose, and Y Uekita, and K Hayasaka, and A Asano, and S Nishino, and H Mitsuhashi, and K Amo, and N Washizuka, and I Mure, and Y Yamashita
October 1986, Nihon Sanka Fujinka Gakkai zasshi,
Y Kikuchi, and J Hirose, and Y Uekita, and K Hayasaka, and A Asano, and S Nishino, and H Mitsuhashi, and K Amo, and N Washizuka, and I Mure, and Y Yamashita
January 2019, Cancer management and research,
Y Kikuchi, and J Hirose, and Y Uekita, and K Hayasaka, and A Asano, and S Nishino, and H Mitsuhashi, and K Amo, and N Washizuka, and I Mure, and Y Yamashita
August 1984, Nihon Gan Chiryo Gakkai shi,
Y Kikuchi, and J Hirose, and Y Uekita, and K Hayasaka, and A Asano, and S Nishino, and H Mitsuhashi, and K Amo, and N Washizuka, and I Mure, and Y Yamashita
January 1976, Bulletin du cancer,
Y Kikuchi, and J Hirose, and Y Uekita, and K Hayasaka, and A Asano, and S Nishino, and H Mitsuhashi, and K Amo, and N Washizuka, and I Mure, and Y Yamashita
May 1986, Gan to kagaku ryoho. Cancer & chemotherapy,
Y Kikuchi, and J Hirose, and Y Uekita, and K Hayasaka, and A Asano, and S Nishino, and H Mitsuhashi, and K Amo, and N Washizuka, and I Mure, and Y Yamashita
June 1982, Geburtshilfe und Frauenheilkunde,
Copied contents to your clipboard!